These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 36690270)

  • 41. Coronary Microvascular Disease in Contemporary Clinical Practice.
    Smilowitz NR; Toleva O; Chieffo A; Perera D; Berry C
    Circ Cardiovasc Interv; 2023 Jun; 16(6):e012568. PubMed ID: 37259860
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of vessel volume on thermodilution measurements in patients with coronary microvascular dysfunction.
    Sakai K; Storozhenko T; Mizukami T; Ohashi H; Bouisset F; Tajima A; van Hoe L; Gallinoro E; Botti G; Mahendiran T; Pardaens S; Brouwers S; Fawaz S; Keeble TR; Davies JR; Sonck J; De Bruyne B; Collet C
    Catheter Cardiovasc Interv; 2024 May; 103(6):885-896. PubMed ID: 38566527
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Coronary microvascular dysfunction is associated with poor glycemic control amongst female diabetics with chest pain and non-obstructive coronary artery disease.
    Sara JD; Taher R; Kolluri N; Vella A; Lerman LO; Lerman A
    Cardiovasc Diabetol; 2019 Feb; 18(1):22. PubMed ID: 30819191
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Beyond Coronary Artery Disease: Assessing the Microcirculation.
    Pruthi S; Siddiqui E; Smilowitz NR
    Cardiol Clin; 2024 Feb; 42(1):125-135. PubMed ID: 37949533
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Coronary Microvascular Disease Registry (CMDR): Study design and rationale.
    Case BC; Merdler I; Medranda GA; Zhang C; Ozturk ST; Sawant V; Garcia-Garcia HM; Satler LF; Ben-Dor I; Hashim HD; Waksman R
    Cardiovasc Revasc Med; 2024 Sep; 66():63-67. PubMed ID: 38631936
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diastolic dysfunction measured by cardiac magnetic resonance imaging in women with signs and symptoms of ischemia but no obstructive coronary artery disease.
    Wei J; Mehta PK; Shufelt C; Yang Y; Gill E; Kahlon R; Cook-Wiens G; Minissian M; Kar S; Thomson L; Berman D; Merz CN
    Int J Cardiol; 2016 Oct; 220():775-80. PubMed ID: 27394973
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Berries and Their Polyphenols as a Potential Therapy for Coronary Microvascular Dysfunction: A Mini-Review.
    Najjar RS; Schwartz AM; Wong BJ; Mehta PK; Feresin RG
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33806050
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of non-invasive imaging parameters in coronary microvascular disease: a systematic review.
    Groepenhoff F; Klaassen RGM; Valstar GB; Bots SH; Onland-Moret NC; Den Ruijter HM; Leiner T; Eikendal ALM
    BMC Med Imaging; 2021 Jan; 21(1):5. PubMed ID: 33407208
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reproducibility of bolus versus continuous thermodilution for assessment of coronary microvascular function in patients with ANOCA.
    Gallinoro E; Bertolone DT; Fernandez-Peregrina E; Paolisso P; Bermpeis K; Esposito G; Gomez-Lopez A; Candreva A; Mileva N; Belmonte M; Mizukami T; Fournier S; Vanderheyden M; Wyffels E; Bartunek J; Sonck J; Barbato E; Collet C; De Bruyne B
    EuroIntervention; 2023 Jun; 19(2):e155-e166. PubMed ID: 36809253
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Understanding Patient Characteristics and Coronary Microvasculature: Early Insights from the Coronary Microvascular Disease Registry.
    Case BC; Merdler I; Medranda GA; Zhang C; Ozturk ST; Sawant V; Margulies AD; Ben-Dor I; Waksman R; Hashim HD
    Am J Cardiol; 2023 Oct; 205():97-103. PubMed ID: 37597488
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Coronary microvascular dysfunction and cancer therapy-related cardiovascular toxicity.
    Chitturi KR; Bhogal S; Kassaian SE; Merdler I; Abusnina W; Chaturvedi A; Ben-Dor I; Waksman R; Case BC; Barac A; Hashim HD
    Cardiovasc Revasc Med; 2024 Nov; 68():45-49. PubMed ID: 38789343
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Coronary Microvascular Dysfunction: What Clinicians and Investigators Should Know.
    Marano P; Wei J; Merz CNB
    Curr Atheroscler Rep; 2023 Aug; 25(8):435-446. PubMed ID: 37338666
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reduced Microvascular Blood Volume as a Driver of Coronary Microvascular Disease in Patients With Non-obstructive Coronary Artery Disease: Rationale and Design of the MICORDIS Study.
    Vink CEM; van de Hoef TP; Götte MJW; Eringa EC; Appelman Y
    Front Cardiovasc Med; 2021; 8():730810. PubMed ID: 34660730
    [No Abstract]   [Full Text] [Related]  

  • 54. Implementation of Microcirculation Examination in Clinical Practice-Insights from the Nationwide POL-MKW Registry.
    Januszek R; Kołtowski Ł; Tomaniak M; Wańha W; Wojakowski W; Grygier M; Siłka W; Jan Horszczaruk G; Czarniak B; Kręcki R; Guzik B; Legutko J; Pawłowski T; Wnęk P; Roik M; Sławek-Szmyt S; Jaguszewski M; Roleder T; Dziarmaga M; Bartuś S
    Medicina (Kaunas); 2024 Feb; 60(2):. PubMed ID: 38399564
    [No Abstract]   [Full Text] [Related]  

  • 55. Coronary Microvascular Dysfunction: A Practical Approach to Diagnosis and Management.
    Bechsgaard DF; Prescott E
    Curr Atheroscler Rep; 2021 Jul; 23(9):54. PubMed ID: 34268637
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Primary versus iatrogenic (post-PCI) coronary microvascular dysfunction: a wire-based multimodal comparison.
    Hasdemir H; Taş A; Cevik E; Alan Y; Broyd CJ; Ozcan A; Sonsoz MR; Kara I; Demirtakan ZG; Parker K; Perera D; Umman S; Sezer M
    Open Heart; 2023 Nov; 10(2):. PubMed ID: 38011991
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Developments and Controversies in Invasive Diagnosis of Coronary Microvascular Dysfunction in Angina With Nonobstructive Coronary Arteries.
    Denby KJ; Zmaili M; Datta S; Das T; Ellis S; Ziada K; Lerman A; Raphael CE
    Mayo Clin Proc; 2024 Sep; 99(9):1469-1481. PubMed ID: 39232622
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Coronary microvascular dysfunction affects left ventricular global longitudinal strain response to dipyridamole stress echocardiography: a pilot study.
    Tagliamonte E; Sperlongano S; Montuori C; Riegler L; Scarafile R; Carbone A; Forni A; Radmilovic J; Di Vilio A; Astarita R; Cice G; D'Andrea A
    Heart Vessels; 2023 Apr; 38(4):470-477. PubMed ID: 36380229
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Angina relates to coronary flow in women with ischemia and no obstructive coronary artery disease.
    Suppogu N; Wei J; Quesada O; Shufelt C; Cook-Wiens G; Samuels B; Petersen JW; Anderson RD; Handberg EM; Pepine CJ; Bairey Merz CN
    Int J Cardiol; 2021 Jun; 333():35-39. PubMed ID: 33662486
    [TBL] [Abstract][Full Text] [Related]  

  • 60. FT4/FT3 ratio: A novel biomarker predicts coronary microvascular dysfunction (CMD) in euthyroid INOCA patients.
    Zhang H; Che W; Shi K; Huang Y; Xu C; Fei M; Fan X; Zhang J; Hu X; Hu F; Qin S; Zhang X; Huang Q; Yu F
    Front Endocrinol (Lausanne); 2022; 13():1021326. PubMed ID: 36187090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.